Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Clin Breast Cancer. 2015 Jun 18;15(6):458–466. doi: 10.1016/j.clbc.2015.06.006

Table 3.

Type of treatment by pathologic T category and Recurrence Score (RS) a

Type of Treatment All Low RS Intermediate RS High RS P Value
All T categories

HT alone 722 (71.7) 513 (91.4) 201 (56.2) 8 (9.1) <.0001
CT alone 2 (0.2) 0 0 2 (2.3)
CT-HT 266 (26.4) 36 (6.4) 153 (42.7) 77 (87.5)
No treatment 17 (1.7) 12 (2.2) 4 (1.1) 1 (1.1)
Missing treatment data 23 10 12 1
Total 1030 571 370 89

T1a

HT alone 33 (94) 21 (100) 12 (92) 0 .0219
CT-HT 2 (6) 0 1 (8) 1 (100)
Total 35 21 13 1

T1b

HT alone 204 (75.3) 147 (96.1) 56 (58.9) 1 (4.3) <.0001
CT-HT 67 (24.7) 6 (3.9) 39 (41.1) 22 (95.7)
Total 271 153 95 23

T1c

HT alone 485 (71.1) 345 (92.0) 133 (54.1) 7 (11.5) <.0001
CT-HT 197 (28.9) 30 (8.0) 113 (45.9) 54 (88.5)
Total 682 375 246 61

Abbreviations: CT, chemotherapy; HT, hormonal therapy; CT-HT, CT followed by HT.

a

Values in table are number of patients (%) unless otherwise specified. Percentages of patients who received HT alone and CT-HT were calculated after exclusion of patients who received non-guideline-recommended treatments (CT alone, therapeutic abstention) or had missing data.